Bioidentical hormones: what is all the hype about?

@article{Panay2010BioidenticalHW,
  title={Bioidentical hormones: what is all the hype about?},
  author={N. Panay and A. Fenton},
  journal={Climacteric},
  year={2010},
  volume={13},
  pages={1 - 3}
}
Since the publication of the Women’s Health Initiative (WHI) study, we have been trying to fully understand why some of the study participants ran into problems. It is now generally accepted that these problems primarily arose due to an older generation of women being given a relative overdose of hormone replacement therapy (HRT). There has subsequently been a trend towards using lower doses and restricting HRT initiation to women younger than 60 years. However, it is also possible that the… Expand
Has the time for the definitive, randomized, placebo-controlled HRT trial arrived?
  • N. Panay, A. Fenton
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2011
TLDR
The time has come for the definitive, randomized, placebo-controlled HRT trial to be performed, and it is only through this trial that the WHI data can be consigned to history as being completely irrelevant to the population of women typically treated with HRT. Expand
Body identical hormone replacement
  • N. Panay
  • Medicine
  • Post reproductive health
  • 2014
TLDR
The effects that body identical estradiol and progesterone can have, both in the physiological environment and also when replaced as transdermal est radiol and micronised oral progester one are reviewed. Expand
Body Identical Hormone Replacement: The Way Forward?
TLDR
This chapter reviews the effects that body identical estradiol and progesterone can have, both in the physiological environment and also when replaced as transdermal estradio and micronized oral progester one. Expand
Defining bioidentical hormones for menopause-related symptoms
TLDR
This definition clearly and concisely explains the meaning of BHs which should lead to a common understanding of the term and limit confusion among health care providers, the general public and the scientific community. Expand
Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use
  • M. L'hermite
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2017
Abstract Wide rejection of conventional hormone therapy (HT) after the initial publication of the Women's Health Initiative (WHI) led to unjustified use of custom-compounded bioidentical hormones. InExpand
Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use
Wide rejection of conventional hormone therapy (HT) after the initial publication of the Women's Health Initiative (WHI) led to unjustified use of custom-compounded bioidentical hormones. In the USA,Expand
BMS – Consensus statement: Bioidentical HRT
  • N. Panay
  • Medicine
  • Post reproductive health
  • 2019
‘Bioidentical hormones’ are precise duplicates of hormones such as estradiol E2, estriol E3, estrone E1, progesterone, dehydroepiandrosterone, testosterone and levothyroxine as synthesised by theExpand
Body-identical hormone replacement
  • N. Panay
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2012
TLDR
In theory, this manifests in a more physiological systemic effect; factors of coagulation are not activated and neither is the renin – angiotensin – aldosterone cascade, thus reducing the risk of venous thrombosis and hypertension. Expand
Estrogen Therapy in 2017
TLDR
Consideration of MHT for menopausal symptoms should be part of an overall strategy including lifestyle recommendations regarding diet, exercise, smoking cessation, and safe levels of alcohol consumption for maintaining the health of peri- and postmenopausal women. Expand
Cognition and mood in perimenopause: A systematic review and meta-analysis
OBJECTIVE It is suggested that declines in estrogen around menopause are associated with declines in cognitive functioning as well as increased risk of depressive symptoms and depressive disorders.Expand
...
1
2
3
...

References

SHOWING 1-8 OF 8 REFERENCES
KEEPS: The Kronos Early Estrogen Prevention Study
TLDR
The rationale that earlier intervention than that performed in the WHI and HERS trials will provide cardiovascular benefit to women is the driving force behind the Kronos Early Estrogen Prevention Study, or KEEPS. Expand
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
TLDR
Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD. Expand
Reprint of Pharmacological profile of progestins
TLDR
Progestins with antiandrogenic properties may also be used for the treatment of women with preexisting androgen related conditions and may be considered as a fourth-generation of progestins. Expand
Pharmacological profile of progestins.
TLDR
Progestins with antiandrogenic properties may also be used for the treatment of women with preexisting androgen related conditions and may be considered as a fourth-generation of progestins. Expand
Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
TLDR
Combining CEE with cyclic or continuous MPA or cyclic MP protected the endometrium from hyperplastic changes associated with estrogen-only therapy. Expand
Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.
TLDR
The increase in risk of breast cancer observed with the use of CHTs other than estrogen+progester one and estrogen+dydrogesterone seems to apply preferentially to ER+ carcinomas, especially those ER+/PR-, and to affect both ductal and lobular carcinomas. Expand
Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief
TLDR
The data show that both ultra-low-dose regimens are effective in reducing the severity and number of hot flushes compared to placebo, with good safety profiles. Expand
Differential effects of progestogens on breast cancer cell lines.
TLDR
In vitro results indicate that not all progestogens act equally on breast cancer cells, while some (dihydrodydrogesterone (DHD), the active metabolite of dydrogestone, tibolone and progesterone (Prog) alone or combined with estradiol induce apoptosis. Expand